Press Release: Sanofi Pasteur withdraws its marketing authorisation application for Emerflu, pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)

Author (Corporate)
Series Title
Series Details EMA/776824/2010 (6.12.10)
Publication Date 06/12/2010
Content Type

The European Medicines Agency (EMA) was formally notified by Sanofi Pasteur, in December 2010, of its decision to withdraw its application for a centralised marketing authorisation for Emerflu, a pandemic influenza vaccine.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/12/news_detail_001159.jsp&mid=WC0b01ac058004d5c1&murl=menus/news_and_events/news_and_events.jsp
Related Links
EMA: Press Release: EMA/776824/2010 (6.12.10) http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2010/12/WC500099534.pdf
Subject Categories
Countries / Regions